Venue | Kisaco Research

Venue

Boston Convention & Exhibition Center, 415 Summer Street, Boston, MA 02210

The AI Drug Discovery & Development Team invites you to join us at the Boston Convention & Exhibition Center, November 18-20. You can find local accommodation here.

  • Author:

    Peter Clark

    VP, Computational Drug Design
    Novo Nordisk

    Peter Clark

    VP, Computational Drug Design
    Novo Nordisk
  • Author:

    Claire Zhao

    Associate Director, AI/ML & Quantitative & Digital Sciences
    PFIZER

    Claire Zhao

    Associate Director, AI/ML & Quantitative & Digital Sciences
    PFIZER
  • Author:

    Zoran Krunic

    Principal Product Manager
    Amgen

    Since joining Amgen R&D in 2018, Zoran Krunic has been at the forefront of applying Machine Learning to enhance patient outcomes and streamline clinical trial enrollment processes, utilizing comprehensive Electronic Health Records and clinical datasets. His pioneering work in the Quantum Machine Learning space, in collaboration with IBM's Quantum team, has been instrumental in integrating machine learning with quantum computing through IBM’s Qiskit platform.

    Prior to his tenure at Amgen, Zoran developed Machine Learning algorithms at Optum to predict hardware and software failures within complex enterprise architectures. He has a strong background in data engineering and systems development, having contributed significantly to large-scale projects at renowned organizations such as Capital Group and ARCO Petroleum.

    In his current full and part-time endeavors, Zoran is leading the efforts in embracing generative AI technologies, with a particular focus on OpenAI's GPT and Anthropic's Claude-2 models. His work is focused on prompt engineering and its application to code generation, advanced document analysis, and process management, with a commitment to ethical AI practices and data privacy.

    A recognized voice in quantum computing circles, Zoran is a regular presenter at industry conferences and has served on numerous panels discussing the integration of quantum computing and generative AI within the Health Sciences sector.

    With a Master of Science in Electrical Engineering & Computer Science, Zoran continues to explore and contribute to the evolving relationship between quantum computing and artificial intelligence, fostering groundbreaking advancements in healthcare technology.

    Zoran Krunic

    Principal Product Manager
    Amgen

    Since joining Amgen R&D in 2018, Zoran Krunic has been at the forefront of applying Machine Learning to enhance patient outcomes and streamline clinical trial enrollment processes, utilizing comprehensive Electronic Health Records and clinical datasets. His pioneering work in the Quantum Machine Learning space, in collaboration with IBM's Quantum team, has been instrumental in integrating machine learning with quantum computing through IBM’s Qiskit platform.

    Prior to his tenure at Amgen, Zoran developed Machine Learning algorithms at Optum to predict hardware and software failures within complex enterprise architectures. He has a strong background in data engineering and systems development, having contributed significantly to large-scale projects at renowned organizations such as Capital Group and ARCO Petroleum.

    In his current full and part-time endeavors, Zoran is leading the efforts in embracing generative AI technologies, with a particular focus on OpenAI's GPT and Anthropic's Claude-2 models. His work is focused on prompt engineering and its application to code generation, advanced document analysis, and process management, with a commitment to ethical AI practices and data privacy.

    A recognized voice in quantum computing circles, Zoran is a regular presenter at industry conferences and has served on numerous panels discussing the integration of quantum computing and generative AI within the Health Sciences sector.

    With a Master of Science in Electrical Engineering & Computer Science, Zoran continues to explore and contribute to the evolving relationship between quantum computing and artificial intelligence, fostering groundbreaking advancements in healthcare technology.

  • Author:

    Chirag Sacher

    Director, Portfolio Innovation
    Novartis

    Chirag Sacher

    Director, Portfolio Innovation
    Novartis
  • Author:

    Ari Allyn-Feuer

    Director, AI Product
    GSK

    Ari Allyn-Feuer

    Director, AI Product
    GSK
  • Author:

    Mark Adams

    Venture Capital Partner
    Two Bear Capital

    Mark Adams

    Venture Capital Partner
    Two Bear Capital
  • Author:

    Petrina Kamya

    Global Head, AI Platforms, VP Insilico Medicine & President
    Insilico Medicine

    Petrina Kamya

    Global Head, AI Platforms, VP Insilico Medicine & President
    Insilico Medicine
  • Author:

    Arvind Rao

    Associate Professor, Computational Medicine & Bioinformatics
    University of Michigan

    Arvind Rao

    Associate Professor, Computational Medicine & Bioinformatics
    University of Michigan
  • Author:

    Jackie Hunter

    CEO
    OI Pharma Partners

    Jackie Hunter

    CEO
    OI Pharma Partners
  • Author:

    Zhiyong (Sean) Xie

    VP & Head, AI & Data Science
    Xellarbio

    Zhiyong (Sean) Xie

    VP & Head, AI & Data Science
    Xellarbio
  • Author:

    Adam Root

    VP & Head, Protein Sciences
    Generate Biomedicines

    Adam Root

    VP & Head, Protein Sciences
    Generate Biomedicines
  • Author:

    Ethan Pickering

    Head, Data Science & ML Research
    Bayer

    Ethan Pickering

    Head, Data Science & ML Research
    Bayer
  • Author:

    Alex Zhavoronkov

    Co-Founder & CEO
    Insilico Medicine

    Alex Zhavoronkov

    Co-Founder & CEO
    Insilico Medicine
  • Author:

    Virginia Savova

    Senior Director, Head Cell-Targeted Precision Medicine
    AstraZeneca

    Virginia Savova

    Senior Director, Head Cell-Targeted Precision Medicine
    AstraZeneca
  • Author:

    Peter Henstock

    Senior Machine Learning Engineer
    Incyte

    Peter Henstock

    Senior Machine Learning Engineer
    Incyte
  • Author:

    Shane Lewin

    VP, AI & ML
    GSK

    Shane Lewin

    VP, AI & ML
    GSK
  • Author:

    Nevin Gerek Ince

    Director, Data & Solutions Engineering
    Novo Nordisk

    Nevin Gerek Ince

    Director, Data & Solutions Engineering
    Novo Nordisk
  • Author:

    Daniyal Hussain

    Executive Director, Technology Business Development
    GSK

    Daniyal Hussain

    Executive Director, Technology Business Development
    GSK
  • Author:

    Michael Dandrea

    Principal Data Scientist
    Genentech

    Michael Dandrea

    Principal Data Scientist
    Genentech
  • Author:

    Preeya Boppana

    Associate Director, Manufacturing Science & Technology
    AstraZeneca Global Biologics

    Preeya Boppana

    Associate Director, Manufacturing Science & Technology
    AstraZeneca Global Biologics
  • Author:

    Yves Fomekong Nanfack

    PhD, Executive Director, Head, End to End AI Foundations, Large Molecules Research
    Sanofi

    Yves Fomekong Nanfack

    PhD, Executive Director, Head, End to End AI Foundations, Large Molecules Research
    Sanofi